Nature Reviews Clinical Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 94.6 | Q1 | 99.7% | 28.076 | Q1 | 100.0% |
| 2024 | 82.2 | Q1 | 99.7% | 28.675 | Q1 | 100.0% |
| 2023 | 81.1 | Q1 | 99.6% | 21.048 | Q1 | 100.0% |
| 2022 | 78.8 | Q1 | 99.6% | 14.809 | Q1 | 99.9% |
| 2021 | 65.0 | Q1 | 99.2% | 11.764 | Q1 | 99.8% |
| 2020 | — | — | 12.214 | Q1 | 99.8% | |
| 2019 | — | — | 9.882 | Q1 | 99.8% | |
| 2018 | — | — | 9.468 | Q1 | 99.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1759-4774
ISSN
1759-4782
region
Western Europe
coverage
2009-2026